Tauriga Sciences Inc (fka TAUG)

[Johnny_C]

Of course the dilution was caused by the malpractice. Any thoughts contrary to that are as absurd as someone thinking that this lawsuit will not fly and that Seth invited Berman to the mediation to part of TEAM HERZOG.

1. TAUG had a R/M they were working on in July of 2015. I doubt Seth was going to Poland on a site seeing trip. It is also a fact that that company has done very well and has had a major company funding it. ( I wonder what company that was and who was acting as point guard on the negotiations LOL) As a public example DECN obviously wanted to merge with TAUG, so any thoughts that TAUG could not do an M&A are also absurd. DECN/Berman seems to still be in the midst of a temper tantrum since Seth told Berman NO DEAL. Berman wanted Seth to settle a couple weeks ago and thought he could still merge with TAUG..

2. As you have pointed out, TAUG itself has had nominal operations, so the expenses were nominal. Did TAUG also have other opportunities to merge but couldn't because of the lawsuit.

3. TAUG would not have been removed from the OTCQB and would not have had to raise so much money at .0042 and now .00125.

4. What is known through public filings is the dilution, why don't you do the math and figure out how many shares came from the defaults. You should be able to figure that out. I think about 80% of the dilution was due to malpractice, and one billion shares may be conservative by the time the November trial comes about. There are attorneys fees still, a couple more possible depositions or re depos, expert witness fees ect, Lets say those are another $250 to $300k, how much more dilution will the malpractice have caused. That looks to be about 300 million more shares right there.

5. How would you propose that TAUG management deliver income the last few years when the major they had to concentrate on getting current with its filings and pay the expenses to keep the lawsuit active against a well funded insurance company.

6. How many other merge opportunities did TAUG miss out on besides Zortrax and the TAUG rejected DECN R/M? And what ws the true cost to shareholders if the malpractice and the audit being unlawful caused the Zortrax deal to fail. Could TAUG have had a 100 mil or 200 mil market cap. You have heard of lost opportunity damages in lawsuits, right.

How about naming a couple of auditors or lawyers or consultants or ANY non-employees of an issuer who were made to restore shares to a company that they weren't issued in the first place in circumstances even vaguely similar to those that exist here? Maybe just one.

The dilution is very easily provable. Experts will try to calculate what the dilution is worth and how much the shares can be bought back for. Maybe they will come up with an amount of .005, maybe .01. This will be done with mathematical models but in the end only one question has to be asked.

Mr. Expert, can you 100% guarantee the shareholders of TAUG that TAUG can buy back all of the diluted shares for the Price per share your model has come up with?

What do you think the answer will be?